Title : Selective RET kinase inhibition for patients with RET-altered cancers.

Pub. Date : 2018 Aug 1

PMID : 29912274






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A second patient with KIF5B-RET fusion-positive lung cancer, acquired resistance to alectinib and symptomatic brain metastases experienced a dramatic response in the brain, and her symptoms resolved. alectinib ret proto-oncogene Homo sapiens